Efficacy of Bevacizumab and Gemcitabine in Combination with Cisplatin in the Treatment of Esophageal Cancer and the Effect on the Incidence of Adverse Reactions

Table 4

The incidence of ototoxicity and nephrotoxicity.

Groups		Ototoxicity	Nephrotoxicity
Control group	50	7	9
Study group	50	5	11
		0.379	0.250
		0.538	0.617